Details for Patent: 7,776,895
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,776,895 protect, and when does it expire?
Patent 7,776,895 protects ANORO ELLIPTA, BREO ELLIPTA, and TRELEGY ELLIPTA, and is included in three NDAs.
This patent has fifty-three patent family members in thirty countries.
Summary for Patent: 7,776,895
Title: | Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases |
Abstract: | The invention provides inhalation devices comprising a compound which is 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyet- hyl}-2-(hydroxymethyl)phenol; or a salt or solvate thereof, inhalation devices comprising formulations and combinations of the compound or a salt or solvate thereof, and methods for the treatment or prophylaxis of a clinical condition in a mammal by employing the inhalation devices. |
Inventor(s): | Box; Philip Charles (Stevenage, GB), Coe; Diane Mary (Stevenage, GB), Looker; Brian Edgar (Stevenage, GB), Mann; Inderjit Singh (Stevenage, GB), Procopiou; Panayiotis Alexandrou (Stevenage, GB) |
Assignee: | Glaxo Group Limited (Greenford, Middlesex, GB) |
Application Number: | 12/211,322 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Delivery; |
Drugs Protected by US Patent 7,776,895
Foreign Priority and PCT Information for Patent: 7,776,895
International Family Members for US Patent 7,776,895
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 036874 | See Plans and Pricing | |||
Argentina | 091595 | See Plans and Pricing | |||
Austria | 417606 | See Plans and Pricing | |||
Australia | 2002326026 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |